243 related articles for article (PubMed ID: 16502423)
1. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
2. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle.
Gosselin LE; Williams JE; Deering M; Brazeau D; Koury S; Martinez DA
Muscle Nerve; 2004 Nov; 30(5):645-53. PubMed ID: 15389721
[TBL] [Abstract][Full Text] [Related]
3. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone.
Gosselin LE; Williams JE; Personius K; Farkas GA
Muscle Nerve; 2007 Feb; 35(2):208-16. PubMed ID: 17058274
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of pirfenidone improves cardiac function in mdx mice.
Van Erp C; Irwin NG; Hoey AJ
Muscle Nerve; 2006 Sep; 34(3):327-34. PubMed ID: 16770778
[TBL] [Abstract][Full Text] [Related]
5. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy.
Andreetta F; Bernasconi P; Baggi F; Ferro P; Oliva L; Arnoldi E; Cornelio F; Mantegazza R; Confalonieri P
J Neuroimmunol; 2006 Jun; 175(1-2):77-86. PubMed ID: 16647144
[TBL] [Abstract][Full Text] [Related]
7. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice.
Durham WJ; Arbogast S; Gerken E; Li YP; Reid MB
Muscle Nerve; 2006 Sep; 34(3):298-303. PubMed ID: 16718687
[TBL] [Abstract][Full Text] [Related]
8. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
[TBL] [Abstract][Full Text] [Related]
9. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
11. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
[TBL] [Abstract][Full Text] [Related]
12. [Effect of pentoxifylline on the expression of hepatic TGF-beta 1, type I and type III collagen in mice with liver fibrosis due to Schistosoma japonicum infection].
Xiong LJ; Luo DD; Zeng LL; Li SL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):209-11. PubMed ID: 12568020
[TBL] [Abstract][Full Text] [Related]
13. Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.
Morrison J; Palmer DB; Cobbold S; Partridge T; Bou-Gharios G
Am J Pathol; 2005 Jun; 166(6):1701-10. PubMed ID: 15920155
[TBL] [Abstract][Full Text] [Related]
14. The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy.
Dorchies OM; Reutenauer-Patte J; Dahmane E; Ismail HM; Petermann O; Patthey- Vuadens O; Comyn SA; Gayi E; Piacenza T; Handa RJ; Décosterd LA; Ruegg UT
Am J Pathol; 2013 Feb; 182(2):485-504. PubMed ID: 23332367
[TBL] [Abstract][Full Text] [Related]
15. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
16. Mdx respiratory impairment following fibrosis of the diaphragm.
Ishizaki M; Suga T; Kimura E; Shiota T; Kawano R; Uchida Y; Uchino K; Yamashita S; Maeda Y; Uchino M
Neuromuscul Disord; 2008 Apr; 18(4):342-8. PubMed ID: 18358722
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
Bizario JC; Cerri DG; Rodrigues LC; Oliveira GL; Nomizo A; de Araujo DD; Fukuhara PS; Ribeiro JC; de Castro FA; Costa MC
J Neuroimmunol; 2009 Jul; 212(1-2):93-101. PubMed ID: 19508953
[TBL] [Abstract][Full Text] [Related]
18. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
Stedman HH; Sweeney HL; Shrager JB; Maguire HC; Panettieri RA; Petrof B; Narusawa M; Leferovich JM; Sladky JT; Kelly AM
Nature; 1991 Aug; 352(6335):536-9. PubMed ID: 1865908
[TBL] [Abstract][Full Text] [Related]
19. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
Radley HG; Davies MJ; Grounds MD
Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
[TBL] [Abstract][Full Text] [Related]
20. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]